Literature DB >> 563542

Status epilepticus in pregnancy: effect of phenytoin malabsorption on seizure control.

R E Ramsay, R G Strauss, B J Wilder, L J Willmore.   

Abstract

In the second trimester of pregnancy in a 26-year-old woman, marked exacerbation of epileptic seizures occurred with somatomotor status epilepticus. The oral requirement of phenytoin varied, and up to 1,200 mg per day were needed to maintain a therapeutic plasma concentration during the second trimester. Intestinal malabsorption was shown to be a causal factor; 56 percent of the daily oral dose of phenytoin was found in the stool. Late in pregnancy and postpartum, therapeutic plasma concentrations of phenytoin were maintained with decreased daily oral doses. Intestinal absorption improved postpartum.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 563542     DOI: 10.1212/wnl.28.1.85

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Plasma concentrations of carbamazepine and carbamazepine 10,11-epoxide during pregnancy and after delivery.

Authors:  D Battino; S Binelli; L Bossi; R Canger; D Croci; C Cusi; M De Giambattista; G Avanzini
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

Review 2.  Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics.

Authors:  H Nau; W Kuhnz; H J Egger; D Rating; H Helge
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

3.  Antiepileptic drugs: metabolism in pregnancy.

Authors:  M Dam; J Christiansen; O Munck; K I Mygind
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

4.  Recent advances in drug therapy for epilepsy.

Authors:  J Bruni
Journal:  Can Med Assoc J       Date:  1979-04-07       Impact factor: 8.262

5.  Bioavailability and pharmacokinetics of phenytoin during pregnancy.

Authors:  C M Lander; M T Smith; J B Chalk; C de Wytt; P Symoniw; I Livingstone; M J Eadie
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Phenytoin metabolism during pregnancy.

Authors:  M J Eadie; G E McKinnon; R G Dickinson; W D Hooper; C M Lander
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 7.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

8.  The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin.

Authors:  R G Dickinson; W D Hooper; B Wood; C M Lander; M J Eadie
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

Review 9.  Drug treatment of epilepsy: a review.

Authors:  D Rosenbloom; A R Upton
Journal:  Can Med Assoc J       Date:  1983-02-01       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.